Acadia’s Remlifanserin Nears Phase III Completion for Alzheimer’s Disease Psychosis 1 year ago ByJohnIn Breaking NewsClinical TrialsDeals
Personalized Neoantigen Vaccine Induces Durable Remission in Advanced Kidney Cancer 1 year ago ByJohnIn DealsFDA ApprovalsResearch Updates
Boehringer Ingelheim’s Nerandomilast Hits Home Run in Phase III FIBRONEER-ILD Trial for Progressive Pulmonary Fibrosis 1 year ago ByJohnIn Deals
MHRA Unveils Streamlined Clinical Trial Guidance, Enhancing Safety Reporting & Trail Oversight 1 year ago ByJohnIn Clinical TrialsResearch Updates
Next-Gen Weight-Loss Drugs Aim to Preserve Muscle, Redefining Obesity Treatment 1 year ago ByJohnIn BreakthroughsPharma Industry UpdatesTop Stories
Uvax Bio Appoints CBO Kevin O’Neill as Interim CEO Amid Strategic Transition 1 year ago ByJohnIn Pharma Industry UpdatesResearch Updates
Novartis Accelerates Stroke Prevention Strategy with $3.1B Acquisition of Anthos 1 year ago ByJohnIn DealsLeadersResearch Updates
India Poised to Become Key Hub for Early-Stage Clinical Trials: Parexel’s Strategic Expansion 1 year ago ByJohnIn BreakthroughsTop Stories
FDA Approves First Oral Therapy for Severe Eczema in Adolescents 1 year ago ByJohnIn Biopharma HighlightsBreaking NewsFDA ApprovalsLeaders
J&J Pulls the Plug on Alzheimer’s Seltorexant and Other Neuroscience Programs 1 year ago ByJohnIn Pharma Industry UpdatesTop Stories
Vertex Wins FDA Approval for JOURNAVX™, the First Non-Opioid Oral Pain Signal Inhibitor in Over 20 Years 1 year ago ByJohnIn Breaking NewsBreakthroughsFDA ApprovalsTop Stories
Funding Surge Fuels Innovation: Verdiva, Aviceda, Windward, and Colossal Secure Big Series Rounds in January 1 year ago ByJohnIn Biopharma HighlightsBreakthroughsDealsFunding RoundsLeadersVenture Capital
Atalanta Therapeutics Secures $97M Series B to Advance RNAi Treatments for Epilepsy and Huntington’s Disease 1 year ago ByJohnIn Clinical TrialsInvestmentsPartnershipsResearch UpdatesVenture Capital
Allakos Collapses After Failed Trial in Chronic Hives, Slashing Workforce by 75% 1 year ago ByJohnIn Clinical TrialsDealsResearch UpdatesStartupsTop Stories
Sarepta’s Gene Therapy Elevidys Shows Positive Phase III Results in Duchenne Muscular Dystrophy 1 year ago ByJohnIn AI & DataClinical TrialsInnovationLeaders
